Synthesis of Fluorinated Radiopharmaceuticals via Electrochemical Fluorination
Tech ID: 23802 / UC Case 2013-799-0
Summary
UCLA researchers in the Department of Molecular and Medical Pharmacology have developed efficient and high-yield electrochemical fluorination techniques for aromatic PET tracer synthesis.
Background
Positron emission tomography (PET) is a powerful diagnostic imaging tool and is increasingly being used to detect and monitor cancer, and cardiovascular and neurological diseases. Fluorine-18 (18F) labeled compounds are the most common type of radiotracers utilized for PET imaging due to the radioisotope’s ideal half-life. However, one of their chief limitations is that few methods exist for incorporation of 18F into aromatic organic molecules. The majority of existing methods for the incorporation of 18F proceed via nucleophilic substitution reactions, which many pharmaceutical aromatic structures are not readily amenable to, thereby limiting the diversity and development of new PET probes. One approach to making nucleophilic substitution more favorable is to use electrophilic fluorination, but current methods require that F2 gas be used as a carrier. This significantly decreases the radiochemical yield and specific activity, and requires extensive purification and isolation. Therefore, improved synthetic methods are needed for wider access to PET tracers.
Innovation
By means of electrochemistry, UCLA researchers have demonstrated electrochemical radiofluorination synthesis that can proceed under mild conditions with higher efficiency and significantly higher radiochemical yield and specific activity. This new technique provides a path for the production of a variety of aromatic organic compound PET tracers. The approaches uses applied electrode potentials that can be tuned precisely according to the nature of the aromatic hydrocarbons, which minimizes the production of side products, thereby improving yield and reducing the need for extensive purification.
Applications
- New synthetic method for radiolabeled aromatic substrates with 18F
Advantages
- Higher efficiency, higher radiochemical yield and specific activity
- Minimize side products, can be easily purified
State Of Development
Proof-of-concept experiments with the electrochemical technique have been successfully conducted on 18F labeling of benzene, catechol and other derivatives.
Patent Status
United States Of America |
Issued Patent |
10,597,340 |
03/24/2020 |
2013-799 |
|
|